The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 14, 2023

Filed:

May. 20, 2019
Applicant:

Roche Diabetes Care, Inc., Indianapolis, IN (US);

Inventors:

David L. Duke, Fishers, IN (US);

Christian Ringemann, Mannheim, DE;

Chinmay Uday Manohar, Fishers, IN (US);

Alan Greenburg, Indianapolis, IN (US);

Assignee:

ROCHE DIABETES CARE, INC., Indianapolis, IN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 10/40 (2018.01); A61B 5/145 (2006.01); A61M 5/142 (2006.01); A61M 5/172 (2006.01); G16H 20/17 (2018.01);
U.S. Cl.
CPC ...
G16H 50/20 (2018.01); A61B 5/14532 (2013.01); A61M 5/14244 (2013.01); A61M 5/1723 (2013.01); G16H 10/40 (2018.01); G16H 20/17 (2018.01); G16H 50/30 (2018.01); A61M 2005/14208 (2013.01); A61M 2205/35 (2013.01); A61M 2205/3569 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2230/201 (2013.01);
Abstract

Methods and systems are disclosed for treating a person with diabetes by basal rate adjustment of insulin from a therapy delivery device based on risk associated with a glucose state of the person with diabetes. A method may include determining a current risk metric associated with a detected glucose state. The method may include determining a current risk metric associated with the detected glucose state based on a weighted average of cumulative hazard values of return paths generated from a glucose state distribution around a detected glucose state. The method may include calculating an adjustment to a basal rate of a therapy delivery device based on the current risk metric associated with the detected glucose state and a reference risk metric associated with a reference glucose level.


Find Patent Forward Citations

Loading…